Skip to main content

and
  1. Article

    Open Access

    A SARS-CoV-2 neutralizing antibody with extensive Spike binding coverage and modified for optimal therapeutic outcomes

    COVID-19 pandemic caused by SARS-CoV-2 constitutes a global public health crisis with enormous economic consequences. Monoclonal antibodies against SARS-CoV-2 can provide an important treatment option to fight...

    Yu Guo, Lisu Huang, Guangshun Zhang, Yanfeng Yao, He Zhou in Nature Communications (2021)